| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.22 | 1e-05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.094 | 0.09 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.073 | 0.2 |